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My Dean’s Scholars thesis project concerns the development of an enzymatic system for the 
in vitro production of polyketides, which we hope will lead to the discovery of new molecules and 
new medicines.  Modular polyketide synthases (PKSs) are massive enzymes that act as molecular as-
sembly lines to elegantly transform small carboxylic acids into complex polyketides.  Many natural 
polyketides are currently used for their medicinal effects, including the antibiotic erythromycin, the 
immunosuppressant rapamycin, and the anticancer agent epothilone.  A long-term goal of the 
Keatinge-Clay group is to use modified PKSs to create synthetic polyketides, which we hope will 
lead to new  pharmaceutical drugs and valuable chiral intermediates for organic synthesis.  Unfortu-
nately, both the study and practical utility of PKSs are hampered by the low yield of their polyketide 
products – yields from the current protocol rarely exceed one milligram per liter of culture.  To cre-
ate a more efficient, reduced-component platform for studying engineered PKSs and to increase 
their yield, we devised a system for the preparative in vitro production of complex polyketides.  This 
system includes enzymes necessary for the production of polyketide intermediates from propionate, 
a modified PKS to form a synthetic polyketide, and enzymes that aid in the regeneration of ATP 
and NADPH from polyphosphate and glucose, respectively.  Currently, we have isolated and assayed 
most enzymes in the system and are optimizing the system conditions for polyketide yield.  We hy-
pothesize that gram quantities of complex polyketides will be produced using the in vitro system, 
greatly increasing the time and energy efficiency of  polyketide synthesis.
I. Introduction:
For three and a half billion years, life 
on Earth and its chemistry have been evolving. 
Along the way, this process has bestowed upon 
us an innumerable amount of awe-inspiring 
compounds:  DNA, proteins, polysaccharides, 
vitamins, and the other stuff of life.  We hu-
mans are particularly interested in these bio-
logical molecules, as some of them – such as 
the essential nutrients – are necessary prerequi-
sites for our lives, while others – like medicines 
and fibers – help to prolong and improve them. 
It follows that the primary purpose of bio-
chemistry, the study of the chemistry of life, is 
to gain a better understanding of these mole-
cules and the reactions that surround them so 
that we can use this knowledge to further im-
prove and sustain life.  In the following pages, I 
describe the development of a novel biochemi-
cal system that will help to further that purpose 
by allowing us to more easily and more effi-
ciently produce new molecules and new medi-
cines.
Of principal interest to the Keatinge-
Clay group are polyketides, a few of which are 
shown in Figure 1.  A wide array of bacteria, 
fungi, and plants synthesize these small yet 
Figure 1.  A few examples of polyketides 
complex and diverse molecules (1).  These or-
ganisms use polyketides for an extensive variety 
of purposes, including defense, information 
transfer, and pigmentation (2).  Researchers 
have become interested in these molecules be-
cause many of the natural polyketides have 
been shown to have interesting medicinal ef-
fects, including antibiotic, anticancer, immuno-
suppressant, and cholesterol-lowering activity 
(3).  While these properties are what make 
polyketides useful to humans, the reason they 
are so fascinating to researchers is that as com-
plex and diverse as polyketides are, their build-
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ing blocks are some of the simplest in all of 
biochemistry.
Polyketide synthases (PKSs) are nature’s 
elegant method of transforming humble car-
boxylic acids into complex polyketides (Figure 
2 (4)).  These impressive proteins are some of 
the largest enzymes found in all of nature. 
Type I modular PKSs in particular are com-
posed of several distinct modules, each of 
which is a giant multi-domain enzyme itself. 
These PKSs work like molecular assembly lines, 
each module acting as a separate station, adding 
another extender unit to the growing chain and 
then modifying the resulting polyketide.  Since 
each module can modify the growing chain in a 
different way, a great level of complexity can be 
obtained.  The result is an extremely diverse 
group of  natural products.
PKS modules exhibit behavior de-
scribed as promiscuous, meaning that they can 
accept growing polyketide chains of varying 
lengths with remarkable tolerance (5,6). This 
allows researchers to rearrange PKS modules, 
forming enzymes that can produce novel, syn-
thetic polyketides.  By exploiting this property, 
it is theoretically possible to synthesize prodi-
gious collections of unique and novel poly-
ketides, and a long-term goal paramount to the 
Keatinge-Clay group is to produce exhaustive 
libraries of these synthetic polyketides (Figure 
3).
Figure 2. 6-DEB synthase transforms propionate into 6-DEB, a complex polyketide.
Many laboratories share the goal of 
producing large numbers of synthetic poly-
ketides due to the vast number of new mole-
cules and new medicines that could potentially 
be produced.  Libraries of polyketides will 
serve as excellent leads for drug screening, 
which could lead to the next generation of 
pharmaceutical drugs.  Researchers are espe-
cially interested in making drug-screening li-
braries out of polyketides because while many 
of the existing polyketides have useful medici-
nal effects, the natural polyketides represent 
only a tiny fraction of the molecules that could 
potentially be produced by rearranging PKS 
modules (7).  In addition, polyketide libraries 
will serve as an unparalleled resource for or-
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ganic chemists who will use polyketides as sub-
strates for the synthesis of even more complex 
“unnatural” natural products.  Polyketides are 
especially useful for this purpose due to their 
chirality, a property that is difficult for organic 
chemists to introduce into their creations by 
tradition methods (8). 
 It is no wonder, then, why many re-
searchers are so interested in pursuing libraries 
of synthetic polyketides.  Unfortunately, one 
obstacle standing in the way of the realization 
of this goal is the current protocol for poly-
ketide production.  One must grow and induce 
several liters of bacteria engineered to produce 
the particular polyketide and subsequently ex-
tract the supernatant in which they grow with 
large amounts of organic solvent.  Emulsions 
form upon this extraction, and the solid ob-
tained when this solvent is evaporated is ex-
tremely contaminated.  One must then resus-
pend the sample and purify the polyketide with 
column chromatography.  Finally, this laborious 
procedure results in a low yield of  polyketide.
  
Figure 3.  A sample polyketide library 
 
 We hope to improve the efficiency and 
yield of polyketide production dramatically by 
developing a novel system for the in vitro bio-
synthesis of polyketides. Whereas engineered 
bacteria have ulterior motives, including repro-
duction and metabolism of food, a reduced-
component in vitro system would have the sole 
purpose of producing polyketides, resulting in 
the formation of fewer byproducts.  Further-
more, the resulting system would be a black 
box of sorts in which a variety of purified 
PKSs could be inserted to produce pure poly-
ketides.  In order to construct such a system, it 
is necessary to identify and isolate those en-
zymes necessary for polyketide production.  In 
addition, enzymatic systems for the regenera-
tion of energy-carrying molecules must be in-
cluded.   Finally, all of the parameters in the 
system must be optimized to provide the best 
conditions for polyketide production.  By con-
structing and optimizing such an in vitro system, 
we hypothesize that the yield of polyketides 
will be dramatically increased, making the 
dream of attaining polyketide libraries a much 
more feasible one.
The project of developing an in vitro 
system for the preparative biosynthesis of 
complex polyketides is an involved and arduous 
task.  The gene for each enzyme in the system 
must be cloned and inserted into an expression 
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vector.  Each enzyme must be purified and in-
dividually tested for activity with a unique assay. 
The ideal buffer conditions must be deter-
mined and implemented, and the concentra-
tions of every component of the system must 
be optimized for polyketide yield.  While the 
development of this system is a demanding and 
challenging project, its pursuit is ultimately 
worth the work it requires, for the result will be 
the potential for a generation of new molecules 
and new medicines.
II. Background:
A.  DEBS:  a Paradigmatic PKS
Erythromycin (Figure 1) is the quintes-
sential polyketide.  Ely Lilly discovered this 
powerful antibiotic in 1949 (9), and it remains 
in use today.  Erythromycin was the first mac-
rolide discovered, and its aglycone precursor, 6-
deoxyerythronolide B (6-DEB) (Figure 2) re-
mains the most studied product of any PKS. 
The antibiotic factory that assembles 6-DEB, 
DEB synthase (DEBS), serves as the paradig-
matic PKS.  Amazingly, the six modules of 
DEBS utilize little more than seven molecules 
of propionate and a few  cofactors to manufac-
ture the complexity of 6-DEB.  The study of 
the structure and function of DEBS has helped 
to elucidate the mechanisms by which PKSs 
function to create such complex and diverse 
products. 
1. Fatty Acid and Polyketide Biosynthesis
Each module of a PKS like DEBS is 
analogous to a fatty acid synthase (FAS), with a 
few modifications.  In fatty acid synthesis, the 
FAS accepts sequential acetate units, adding 
another two carbons to the growing fatty acid 
with each additional acetate unit.  The biggest 
difference between a FAS and a PKS module is 
that whereas the FAS must completely reduce 
each additional acetate unit, a PKS module can 
leave the carbonyl carbon of the extender unit 
in any of four reduction states (Figure 4 (10)). 
The module can leave the carbonyl as is, reduce 
it to form a hydroxyl group, dehydrate the car-
bon to form a C-C double bond or completely 
saturate the growing chain just as the FAS 
would.  Thus, we begin to understand why 
PKSs are responsible for the complexity and 
diversity of polyketides while FASs produce the 
relative simplicity and uniformity of  fatty acids.
Type I modular PKSs like DEBS have 
another property that allows their products to 
be much more diverse than fatty acids.  FASs 
are iterative, meaning that a FAS performs the 
same action on each additional extender unit 
until a particular chain length is reached. 
Modular PKSs, however, align multiple mod-
ules together in a molecular assembly line. 
Each module adds one additional extender unit 
to the growing chain and subsequently passes 
the developing polyketide to the next module. 
Since each module can reduce its extender unit 
to a different oxidation state, the product can 
contain many different functional groups in a 
unique order, which results in a much more 
interesting product than a fatty acid.
Figure 4:  Fatty Acid/Polyketide Reduction. 
Whereas a fatty acid synthase must complete the 
complete loop shown, a PKS module may stop the 
reduction at any point.
 Yet another property of many PKSs 
that facilitates complexity is their ability to pro-
duce chiral compounds.  A PKS has three op-
portunities to introduce chirality to its product. 
The formation of a double bond allows for the 
production of either the cis or trans isomer of 
the polyketide.  In addition, a stereocenter is 
formed when the carbonyl group of the ex-
tender unit is reduced to a hydroxyl group, and 
another arises with a peripheral methyl group if 
propionate is used instead of acetate, as in the 
case of DEBS.  The power of PKSs to exhibit 
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stereoselectivity, oxidative control, and modu-
larity enables PKSs to manufacture complex 
macrolides like 6-DEB.  
 From Propionate to Polyketide
From its life as a Lilliputian carboxylic 
acid to its incorporation into 6-DEB, propion-
ate takes an epic journey.  Before it can be used 
by DEBS, propionate must first be altered into 
methylmalonyl-CoA.  In one route to this 
form, propionate-CoA ligase first joins propi-
onate to coenzyme A, using ATP in the proc-
ess.   Next, propionyl-CoA carboxylase uses 
bicarbonate and another ATP to carboxylate 
propionyl-CoA, forming methylmalonyl-CoA. 
This activates the substrate to increase the 
thermodynamic favorability of polyketide chain 
extension.  In addition, propionyl-CoA car-
boxylase exhibits stereocontrol, forming only 
the (2S) isomer of methylmalonyl-CoA, which 
is the only form that DEBS can accept.  After 
these steps are performed, propionate is finally 
ready for its date with the polyketide assembly 
line.
DEBS is a prodigious protein, consist-
ing of six modules on three peptides connected 
by interpolypeptide linkers which are then di-
merized to form a massive protein complex 
(11).  Each module of DEBS consists of sev-
eral catalytic domains, similar to a FAS.  Three 
of these domains are responsible for chain 
length extension, three reduce the extender 
units to varying degrees, and a terminal thio-
esterase cleaves the finished polyketide from 
DEBS upon completion of  the assembly line.
The first of these domains, the acyl car-
rier protein (ACP) binds to methylmalonyl-CoA 
and guides it along the hardware of the module 
until all the chemistry is complete.  The ACP is 
posttranslationally bound to a phosphopan-
tethienyl arm via a conserved serine residue. 
This arm takes the place of coenzyme A on 
methylmalonyl-CoA as it bonds to the ACP, 
and its flexibility allows the ACP to shuttle the 
growing polyketide chain to each of the do-
mains in the module.
The first action of the ACP is to travel 
to the acyl transferase domain (AT), where the 
AT catalyzes the binding of an extender unit to 
the ACP.  For all six of the modules of DEBS, 
this extender unit is methylmalonate, but an 
additional AT joins an initial starter unit of 
propionate in the loading didomain (LDD) in 
front of  module 1.
After it travels to the AT, the ACP next 
moves to the adjacent β-ketoacyl-S-ACP syn-
thase domain (KS) where the growing poly-
ketide chain is extended.  The purpose of the 
KS is to accept the growing polyketide chain 
from the previous module (or LDD in the case 
of module 1) and catalyze chain extension.  Just 
as in fatty acid synthesis, the decarboxylation of 
methylmalonate on the ACP allows the growing 
polyketide chain to be transferred from the KS 
to the extender unit on the ACP.  The entire 
polyketide chain now extends from the phos-
phopantethienyl arm of the ACP and is ready 
to move to the reductive section of  domains.
The first stop for the growing chain in 
the reductive loop of domains is the ketoreduc-
tase (KR).  This domain reduces the carbonyl 
in the β  position of the polyketide chain to 
form a hydroxyl group.  In the process, a stere-
ocenter is formed, and a particular KR will al-
ways catalyze the formation of a hydroxyl 
group on the same side of the polyketide chain. 
In addition, the KR has stereocontrol over the 
methyl group extending off the chain that re-
sults from the extension with methylmalonate. 
The KR is thus responsible for the orientation 
of two stereocenters.  In some cases, such as 
the third module of DEBS, the KR is said to 
be “inactive,” in which case the module con-
tains a KR but does not reduce the carbonyl 
group; however, these domains still retain 
stereocontrol over the peripheral methyl group 
and thus are not inactive but rather represent a 
separate category of  KR domains.  
If the carbonyl group of the growing 
chain is reduced, the ACP may next pass to a 
dehydratase domain (DH), which catalyzes the 
dehydration of the hydroxyl formed at the KR, 
resulting in a C-C double bond.  Again, the 
PKS exhibits stereocontrol, as a DH can cata-
lyze the formation of the cis or trans isomer. 
Only the fourth module of DEBS contains a 
DH.
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If a PKS module contains a full reduc-
tive loop, then the ACP will last transfer the 
growing chain to an enoyl reductase domain 
(ER).  Here, the C-C double bond is reduced to 
completely saturate the original carbonyl car-
bon, as in fatty acid synthesis. These three do-
mains – the KR, DH, and ER – are all optional, 
and the diversity of presence or lack thereof 
within the modules of a PKS results in the 
great diversity that we see in polyketides like 6-
DEB.  
After the ACP brings the polyketide 
chain through the reductive section of its mod-
ule, it finally passes the chain to the KS of the 
next module, and the process is repeated.  In 
this manner, DEBS begins with a starter unit of 
propionate bound to the KS of module 1 by 
the LDD and systematically adds six extender 
units of propionate, each modified by a subse-
quent module.
When the growing polyketide chain 
reaches the end of the assembly line, a terminal 
thioesterase (TE) domain catalyzes the hydroly-
sis of the polyketide from the phosphopan-
tethienyl arm of the ACP to form a carboxylic 
acid, which, in the case of 6-DEB, cyclizes to 
form a macrolide.  Thus, DEBS, the paradig-
matic PKS, masterfully takes six molecules of 
methylmalonyl-CoA and one molecule of 
propionate-CoA and creates 6-DEB, the agly-
cone precursor to erythromycin.  
2. Polyketide Libraries
Since each module of a PKS can per-
form different chemistry on the growing chain, 
the number of possible molecules that could be 
created by a PKS is seemingly endless.  From 
Figure 2 we see that three of the six DEBS 
modules – 2, 5, and 6 – perform the same 
chemistry on the growing polyketide, but even 
with only 4 distinct module types, there are 46 
or 4096 different polyketides that could be 
produced from a six-membered PKS assembly 
line using DEBS modules.  Include all of the 
different modules observed in nature from dif-
ferent organisms, and the number of possible 
polyketides is enormous.
By genetically engineering PKSs to con-
tain novel sequences of modules, researchers 
are attempting to create exhaustive libraries of 
synthetic polyketides.  These libraries are a 
common goal among polyketide scientists due 
to their potential as drug screening subjects and 
precursors for organic synthesis.  Because syn-
thetic polyketides share the structures of natu-
ral polyketides, many of which are now used as 
medicines, it is reasonable to hypothesize that 
libraries of polyketides will be better subjects 
for drug screening than other synthetic prod-
ucts.  In addition, the presence of chiral groups 
makes polyketides attractive starting materials 
for the organic synthesis of “unnatural” natural 
products.  Both of these applications give 
polyketides the potential to lead to the next 
generation of  pharmaceutical drugs.
Standing in the way of polyketide li-
braries is the current protocol for purifying 
polyketides.  Host cells engineered to produce 
the PKS of interest must be grown, and after 
they are induced to synthesize polyketides, the 
supernatant in which they grow must be ex-
tracted.  The resulting product is very impure, 
and the yield of polyketide that results after 
column chromatography is extremely minimal 
– only a few milligrams per liter of cells.  To 
bypass this obstacle, we designed a reduced-
component in vitro system for the production of 
polyketides.  We hypothesize that this system 
will dramatically increase the yield of poly-
ketide production – making the goal of poly-
ketide libraries a reality and unleashing the full 
potential of PKSs as manufacturers of new 
medicines.
B.  In Vitro Polyketide Production
Before we could make polyketides in 
vitro, we first needed to design a suitable sys-
tem.  This system needed to contain the neces-
sary components to perform three tasks.  First, 
it needed to use enzymes to convert propionate 
into (2S)-methylmalonyl-CoA and propionyl-
CoA, the substrates for DEBS (as described 
above).  Next, the system needed to contain a 
PKS to take these substrates and convert them 
into the polyketide of  interest.  Finally, 
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the system needed enzymes that could regener-
ate the energy-carrying cofactors necessary for 
polyketide production, ATP and NADPH, in 
order for polyketide yield to be substantial.  In 
addition to these enzymes, we needed to in-
clude all the substrates necessary for these reac-
tions and provide the ideal conditions for the 
enzymes with a buffer system.  Once this sys-
tem was constructed, the in vitro production of 
polyketides would be possible.  
1. The Main Pathway
 Before propionate can be incorporated 
into a polyketide by a PKS, it must first be 
modified.  DEBS uses propionyl-CoA to prime 
its first module with propionate, as a FAS does 
with acetate.  Each module then decarboxylates 
methylmalonyl-CoA in order to add a three-
carbon extender unit to the growing polyketide 
chain.  To form polyketides in vitro, we could 
simply add these substrates directly; however, it 
would be much cheaper to add propionic acid 
instead and form propionyl- and methyl-
malonyl-CoA in situ.
 Streptomyces coelicolor bacteria contain 
genes for propionate-CoA ligase (PrpE) and 
propionyl-CoA carboxylase (a complex of two 
enzymes, AccA1 and PccB), which form 
propionyl-CoA and subsequently methyl-
malonyl-CoA, respectively.  The first step of 
the in vitro system (Figure 5), then, involves 
these two enzymes, which transform cheap 
propionic acid into usable substrates for the 
PKS.
2. An Alternate Route
Another method to form propionyl- 
and methylmalonyl-CoA from simple sub-
strates involves a different pair of enzymes. 
Erythromycin-producing bacteria S. coelicolor 
and Saccharopolyspora erythrae contain genes for 
methylmalonate-CoA ligase (MatB) and 
methylmalonyl-CoA epimerase.  The first of 
these enzymes fuses coenzyme A to methylma-
lonate, forming a racemic mixture of 
methylmalonyl-CoA.  Unfortunately, the (2R) 
epimer of methylmalonyl-CoA is a much more 
abundant product than the (2S) epimer, yet 
DEBS can only accept the latter form.  In addi-
tion, the rate of spontaneous epimerization to 
the (2S) form is extremely slow (12).  In order 
to produce the correct epimer, S. coelicolor and 
S. erythrae use methylmalonyl-CoA epimerase. 
Thus, an alternate pathway to the correct sub-
strates for DEBS involves the addition of 
methylmalonate and these two enzymes.
3. Polyketide Synthase
Once the correct substrates are formed in vitro, 
a PKS must be present to transform them into 
the polyketide of interest.  Once the in vitro sys-
tem is completed and optimized, this element 
of the system will be exchanged for various 
PKSs, allowing for the production of poly-
ketide libraries.  In the mean time, we needed a 
simple PKS that would allow for the produc-
tion of a familiar product that could be ana-
lyzed to quantify polyketide yield.
 DEBS1 refers to the first of the three 
polypeptides of DEBS.  It contains the first 
two modules of DEBS plus the LDD domain 
that primes DEBS with propionate.  The addi-
tion of a three-carbon extender unit by each of 
the modules results in a triketide bound to the 
ACP of the second module.  By engineering a 
TE domain at the end of module 2, this tri-
ketide can be cleaved off.  In solution, this tri-
ketide will then cyclize to form a triketide lac-
tone (TKL).  We received plasmids containing 
the genes for the LDD-Mod1 of DEBS as well 
as Mod2-TE from Kosan Biosciences.  After 
protein expression and purification, we inserted 
these proteins into the in vitro system to form 
the TKL shown in figure 5.
4. Energy Regeneration
The enzymes involved in polyketide 
production from propionate use the energy-
carrying molecules ATP and NADPH.  These 
substrates are expensive, so we included sys-
tems to regenerate these molecules in order to 
maximize the efficiency of  the in vitro system.
Propionyl-CoA carboxylase uses ATP 
and bicarbonate to produce methylmalonyl-
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CoA from propionyl-CoA, forming ADP in the 
process.  In order to regenerate ATP from 
ADP, polyphosphate kinase (PPK) is used. 
This enzyme catalyzes the transfer of a phos-
phate group from polyphosphate, a very cheap 
substrate, to ADP to form ATP.  
In the first step of the in vitro system, 
propionate-CoA ligase uses ATP to form 
propionyl-CoA, forming AMP in the process. 
To regenerate ATP from AMP, adenylate kinase 
(AdK) is first used to transfer a phosphate 
from ATP to AMP to form two molecules of 
ADP.  Polyphosphate kinase can then regener-
ate ATP from ADP as discussed above.
Propionate-CoA ligase also forms inor-
ganic pyrophosphate, the presence of which 
could lead to product inhibition.  In order to 
rid the solution of pyrophosphate, inorganic 
pyrophosphatase (IP) is added to the system. 
This enzymes catalyzes the hydrolysis of inor-
ganic pyrophosphate to form two molecules of 
phosphate.
Figure 6:  PAGE of several proteins in the in vitro 
system. Columns from left to right:  protein ladder, 
propionyl-CoA carboxylase alpha subunit, pro-
pionyl-CoA carboxylase beta subunit, propionate-
CoA ligase, Sfp (an enzyme for a separate project), 
and polyphosphate kinase.
Finally, the KRs of the PKS use 
NADPH to reduce the growing polyketide 
chain, forming NADP+ in the process.  To re-
generate NADPH, glucose dehydrogenase 
(GDH) is used to oxidize glucose, forming glu-
conolactone and transferring a hydride to 
NADP+.  By regenerating the energy-carrying 
molecules of the in vitro system, the full poten-
tial of the system to increase the efficiency of 
polyketide production will be achieved.
5. Buffer Conditions
In addition to the enzymes described 
above, the correct buffer conditions and sub-
strates must be added to the in vitro system. 
Imidazole at pH 7.8 provides a stable pH. 
Propionic acid provides the starting material 
for polyketide production.  Energy-carrying 
molecules ATP and NADPH must be added, 
and MgCl2 is added to stabilize ATP.  NaHCO3 
is added for the carboxylation of propionyl-
CoA.  Polyphosphate allows for the regenera-
tion of ATP as glucose does for NADPH. 
NaCl provides the correct salinity for the en-
zymes in the system, and BSA further stabilizes 
them.  Finally, coenzyme A must be added to 
form propionyl- and methylmalonyl-CoA.  
III. Results and Discussion
A. Protein Purification
The majority of the work thus far in 
the project has concerned the isolation of the 
enzymes in the system.  While protein purifica-
tion is usually a straightforward task, many of 
the proteins in the system have proven difficult 
to isolate.  The genes for some required ad-
vanced PCR techniques to clone.  In other 
cases, ligating the digested gene into an expres-
sion vector proved less than simple.  Currently, 
we have isolated all of the enzymes in the 
original in vitro system and are assaying them 
for activity.
A few of the enzymes were purified 
with little trouble.  Propionate-CoA ligase 
(PrpE), the beta subunit of propionyl-CoA 
carboxylase (PccB), and polyphosphate kinase 
(PPK) responded well to a standard PCR pro-
tocol, digestion and ligation procedure, and 
immobilized metal affinity chromatography 
(IMAC) (figure 6).  Glucose dehydrogenase 
(GDH) and methylmalonate-CoA ligase were 
purified by other members of the lab.  We re-
ceived plasmids containing the genes for the 
LDD-Mod1 of DEBS as well as Mod2-TE 
from Kosan Biosciences.  Plasmid vectors con-
taining alternate versions of the propionyl-CoA 
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carboxylase enzyme complex proteins were also 
acquired from an outside laboratory and puri-
fied. The remaining enzymes were more diffi-
cult to isolate.
In order to clone the genes for the al-
pha subunit of propionyl-CoA ligase (AccA1), 
adenylate kinase (AdK), inorganic pyrophos-
phatase (IP), and methylmalonyl-CoA epime-
rase (MME), multiple PCR protocols were at-
tempted simultaneously.  Typically, nine proto-
cols were attempted on each gene, utilizing a 
gradient of three DMSO concentrations and 
three different touchdown PCR protocols that 
utilized three different annealing temperature 
ranges.  By performing this 3x3 PCR protocol 
experiment, we have found a PCR protocol 
that successfully clones every gene we have at-
tempted to amplify.  
Figure 7:  Ligase and Carboxylase Assay.  The line 
drawn in pink represents the sample without en-
zyme.  The blue line represents the addition of 
propionate-CoA ligase.  The black line represents 
the addition of the propionyl-CoA carboxylase 
complex.  See text for further description.
While most of the enzymes in the sys-
tem have been successfully isolated, one still 
remains elusive.  The gene for methylmalonyl-
CoA epimerase has been successfully amplified 
from S. erythrae genomic DNA using the 
aforementioned PCR protocol, but several at-
tempts at ligation into pET28b and transforma-
tion into Top Ten heat shock competent E. Coli 
have proven unsuccessful, as judged by check 
digest on the extracted DNA of the resulting 
colonies.  Next, we will attempt to amplify this 
gene from S. Coelicolor instead, and hopefully 
the resulting product will allow us to success-
fully ligate this gene into pET28b.
B.  Enzyme assays
Once each enzyme in the system was 
isolated, it was necessary to assay it for the cor-
rect activity.  So far, all of the assays performed 
have utilized reversed-phase HPLC with UV-
Vis spectrophotometric detection at 264 nm to 
measure the presence of adenine derivatives. 
To separate negatively charged adenine deriva-
tives such as ATP, ADP, and propionyl-CoA on 
a reversed-phase HPLC column, we used a 
buffer containing tetrabutylammonium hydrox-
ide (TBAH), whose butyl moieties bind to the 
hydrophobic column and ammonium moieties 
create anion-exchange conditions.  The result is 
that more negatively charged species take 
longer to elute from the column.  
1. Propionate-CoA Ligase
To assay PrpE, we combined ATP, 
propionate, and CoA with and without the en-
zyme and analyzed the samples with HPLC. 
Figure 7 shows the disappearance of a peak 
for CoA at 5.5 mins and the appearance of a 
peak for propionyl-CoA at 10 mins when the 
enzyme is added, indicating that the desired 
reaction is taking place.
2. Propionyl-CoA Carboxylase
The propionyl-CoA carboxylase enzyme 
complex produces (2S)-methylmalonyl-CoA 
from propionyl-CoA and bicarbonate.  To assay 
this enzyme, the product of the PrpE reaction 
was run on the HPLC with and without the 
addition of AccA1 and PccB.  Figure 7 shows 
the result of this addition.  A peak with a reten-
tion time of about 5.5 minutes appears for the 
sample containing the carboxylase complex. 
Whether this peak represents methylmalonyl-
CoA or unreacted CoA needs to be determined 
by running methylmalonyl-CoA alone on the 
HPLC.  
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Figure 9: LCMS of  triketide lactone produced using the current method. 
C. Positive control
We used the current polyketide extrac-
tion protocol to produce the triketide lactone 
that we hope to synthesize with the in vitro sys-
tem as a positive control.  K207-3 E. Coli engi-
neered by Kosan Biosciences to produce the 
triketide lactone in question were grown, and 
their media was extracted.  The resulting prod-
uct was purified with silica column chromatog-
raphy, and the sample was analyzed with LCMS 
(figure 9).
IV. Conclusion
So far, we have made great progress to-
ward our goal of constructing an in vitro system 
for the preparative biosynthesis of polyketides. 
We have successfully purified most of the en-
zymes in the system, and unique assays have 
been performed on each enzyme isolated to 
test its activity.  Unfortunately, despite this pro-
gress, our first attempts at putting the system 
together have failed to produce a measurable 
amount of  polyketide as judged by LCMS.  
The lack of polyketide production in 
these preliminary attempts likely stems from 
the absence of activity of one of the enzymes 
in the main pathway.  AccA1, the alpha subunit 
of propionyl-CoA carboxylase, proved difficult 
to isolate at first, and even after it was success-
fully purified, our attempts to assay the 
propionyl-CoA carboxylase complex proved 
inconclusive due to inconsistencies in our 
HPLC assay results.  We have obtained alter-
nate versions of the enzymes in the complex in 
hopes that these would give more consistent 
results.  Meanwhile, we are developing different 
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HPLC methods to assay this complex that will 
hopefully be more reliable.
Concurrently, we have attempted to ex-
plore an alternate pathway to methylmalonyl-
CoA that would replace propionate-CoA ligase 
and propionyl-CoA carboxylase.  Instead, 
methylmalonate would be added directly in so-
lution, bound to coenzyme A by methyl-
malonate-CoA ligase, and epimerized to the 
(2S) form with methylmalonyl-CoA epimerase. 
Unfortunately, our attempts to clone the gene 
for the latter enzyme have been thus far unsuc-
cessful.  We are currently troubleshooting this 
purification process, and hopefully we will be 
successful in our attempts soon.
We have also begun investigating a more 
sensitive method for detecting polyketide pro-
duction.  If C14-labeled methylmalonate or 
propionate is used in the system, then radio-
labeled polyketides should be formed.  These 
polyketides can be quantitatively detected by 
using thin layer chromatography and a radioiso-
tope detection system.  This capability will al-
low us to more accurately determine the 
amount of polyketide being produced with the 
in vitro system, and it will facilitate our optimi-
zation of the system once we are successful at 
producing polyketides.
While our attempts at producing poly-
ketides in vitro have been unsuccessful so far, 
we are making progress toward this goal and 
are optimistic.  Once we are successful at syn-
thesizing polyketides with the in vitro system, we 
hope that the system will greatly increase the 
cost and time efficiency of polyketide produc-
tion, increasing the yield dramatically over that 
of the current method.  We hope that this in-
crease in efficiency will allow us to realize our 
long-term goal of creating exhaustive poly-
ketide libraries that will lead to a generation of 
new molecules and new medicines.
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VI. Materials and Methods
The following section serves as a refer-
ence to those wishing to replicate the proce-
dures performed over the course of this pro-
ject.  Herein are listed the various protocols 
used to clone and purify each protein, condi-
tions for each assay performed, and a detailed 
description of the current method for poly-
ketide production.
A.  Protein Cloning Protocols
 1. Standard Cloning Protocol
Several of the proteins purified were 
isolated using the following protocol:  A stan-
dard PCR recipe was performed, and the fol-
lowing temperature conditions were run on a 
thermal cycler:  95˚C for 3 min, followed by 34 
cycles of 95˚C for 30 sec, 65˚C for 30 sec, and 
72˚C for 30 sec, followed by 72˚C for 10 min. 
The resulting fragment was digested 
with Nde1 and Xho1 restriction endonucleases 
and ligated into pET28b.  The recombinant 
vector was transformed into electrocompetent 
XL1-blue cells via electroporation and spread 
on a kanamycin-resistance selection plate of 
LB/agarose.  The resulting colonies were 
grown in 3ml of LB media supplemented with 
kanamycin, and the plasmid DNA was subse-
quently extracted and transformed into K207-3 
cells via electroporation.  These cells were 
grown in 6L of LB media supplemented with 
kanamycin to an OD600 of 0.5 and induced 
with .5mM IPTG.  The cells were then grown 
overnight at 15˚C.
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These cells were centrifuged at 5,000 x 
g for 15 mins, and the resulting cell pellet was 
sonicated in a lysis buffer consisting of .5M 
NaCl and 30mM HEPES pH 7.5 to release the 
protein into solution.  The lysate was centri-
fuged at 30,000 x g.  The supernatant of this 
centrifugation was run over an immobilized 
nickel affinity column primed with the afore-
mentioned lysis buffer.  The column was 
washed with 15mM imidazole in lysis buffer, 
and the protein was eluted with 150mM imida-
zole in lysis buffer.
Using this protocol, adenylate kinase 
was cloned from the genome of K207-3 E. coli 
using the following PCR primers:




 Propionate-CoA ligase was cloned from 






 The beta subunit of propionyl-CoA 
carboxylase was cloned from the genome of 





 Polyphosphate Kinase was cloned from 







Inorganic pyrophosphatase was purified 
in a manner identical to that above except that 
the PCR protocol was modified to have an an-
nealing temperature of 79˚C, and 10% dimethyl 
sulfoxide was added to the PCR reaction.  The 
following primers were used:
F : 5 ’ TCAGTAAGTCATATGTTATT-
ATTCTTTGCGCGCTC
R: 5 ’ AGAGTAGACCTCGAGAGAG-
CTTACTCAACGTCCCTG.  All other proce-
dures were the same as those listed above.
3. Propionyl-CoA Carboxylase Alpha Subunit
The procedure above was modified sig-
nificantly to purify AccA1.  A touchdown PCR 
protocol was utilized along with 10% dimethyl 
sulfoxide.  The touchdown protocol tempera-
tures were as follows:  95˚C for 3 min, followed 
by 5 rounds of 95˚C for 30 sec, 66˚C for 30 sec 
(2˚C cooler at each step), and 72˚C for 1 min. 
This was followed by 30 rounds of 95˚C for 30 
sec, 60˚C for 30 sec, and 72˚C for 1 min.  The 
protocol ended at 72˚C for 8 min.  The protein 
was cloned from the genome of K207-3 E. coli 




CTAAGTAGCAATCG.  Nde1 and EcoR1 en-
donucleases were used.  All other procedures 
were the same as above.
  4. Propionyl-CoA Carboxylase from 
Mycobacterium tuberculosis
Plasmids containing genes for the alpha 
and beta subunits of propionyl-CoA carboxy-
lase were obtained from an outside laboratory. 
These plasmids were transformed into K207-3 
E. coli by electroporation and grown as above 
to an OD600 of .6.  For the alpha subunit, the 
cells were then induced with .5mM IPTG and 
grown at 20˚C overnight.  For the beta subunit, 
the cells were induced with .1mM IPTG and 
grown at 18˚C overnight.  The lysis, wash, and 
elution buffers used for protein purification 
contained 10% w/v glycerol, 150mM NaPO4 
and .5M NaCl.
B.  Detailed Assay info 
 1. Adenylate Kinase
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 A solution of 150mM NaCl, 100mM 
HEPES pH 7.5, 1mM ADP, and 10mM MgCl2 
was prepared with and without the addition of 
adenylate kinase.  The resulting two reactions 
were run on a reversed-phase HPLC with an 
isocratic elution system of methanol supple-
mented with tetrabutylammonium hydroxide. 
The separation was analyzed with UV spectros-
copy at 264 nm.  
 2. Propionate-CoA Ligase and 
Propionyl-CoA Carboxylase
 A solution of 100mM KH2PO4, 12mM 
MgCl2, 50mM NaHCO3, 20mM propionic acid, 
5 mM ATP, and 1mM coenzyme A was pre-
pared with and without the addition of 
propionate-CoA ligase.  These reactions were 
run as above via HPLC.  The subunits of the 
propionyl-CoA carboxylase complex were then 
added to the solution containing the ligase, and 
this reaction was run on the HPLC as well.
 3. Methylmalonate-CoA ligase
A solution of 100mM KH2PO4, 12mM 
MgCl2, 10mM methylmalonic acid, 5 mM ATP, 
and 1mM coenzyme A was prepared with and 
without the addition of methylmalonate-CoA 
ligase.  These reactions were run as above on 
the HPLC.  Data for this assay has not yet been 
collected.
 
C.  Detailed current method protocol
 In a large Fernbach flask, we combined 
M9 media, CaCl2, MgSO4, glucose, β-alanine, 
ampicillin, kanamycin, and E. coli cells engi-
neered previously to produce the desired tri-
ketide lactone.  These cells were grown at 37˚C 
until they reached an OD600 of 0.4.  At this 
point, the heat was reduced to 22˚C, and 
propionic, succinic, and glutamic acids were 
added.  The cells were incubated for 15 min 
before IPTG was added to induce polyketide 
production.  The cells were then incubated 
overnight.
 After incubation, the cells were centri-
fuged at 6000 RPM for 10 min.  The super-
natant was again centrifuged at 7500 RPM. 
The supernatant from this centrifugation was 
pHed to 1.5 with approximately 20ml concen-
trated HCl.  The supernatant was then ex-
tracted twice with ethyl acetate, and MgSO4 was 
added to desiccate the solution.  The organic 
layer was removed, and the solvent was evapo-
rated off.  The resulting product was analyzed 
via a vanillin-stained TLC and LCMS.  The va-
nillin stain consisted of 6g vanillin, 100ml 95% 
ethanol, and 1ml concentrated H2SO4.
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